Last reviewed · How we verify
NCT04782154
Paceport Swan-Ganz Data Collection Study
trial in Right Ventricular Dysfunction in 136 participants. Completed in 1 April 2022.
1 March 2022
Quick facts
| Lead sponsor | Montreal Heart Institute |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 136 |
| Start date | 9 August 2021 |
| Primary completion | 1 March 2022 |
| Estimated completion | 1 April 2022 |
| Sites | 1 location across Canada |
Conditions studied
- Right Ventricular Dysfunction — all drugs for Right Ventricular Dysfunction →
- Right Heart Failure — all drugs for Right Heart Failure →
- Congestive Heart Failure — all drugs for Congestive Heart Failure →
Sponsor
Montreal Heart Institute
Who can join
18 and older, any sex, with Right Ventricular Dysfunction or Right Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
RV dysfunction has been associated with increased mortality in the ICU and cardiac surgical patients. Thus, early identification of RV dysfunction at less severe stages will allow for earlier intervention and potentially better patient outcomes. However, so far, no studies have reported prospectively the prevalence of abnormal RV pressure waveform during cardiac surgery and in the ICU. Our primary hypothesis is that the prevalence of abnormal RV pressure waveform occurs in more than 50% of cardiac surgical patients throughout their hospitalization. Those patients with abnormal RV pressure waveform will be more prone to post-operative complications related to RV dysfunction and failure in the OR and ICU.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Longitudinal Validation of Right Ventricular Pressure Monitoring for the Assessment of Right Ventricular Systolic Dysfunction in a Large Animal Ischemic Model.
Couture EJ, Moses K, Monge García MI, Potes C, et al · · 2023 · cited 4× · PMID 36699251 · DOI 10.1097/cce.0000000000000847
Verify or expand the search:
- PubMed search for NCT04782154
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Right Ventricular Dysfunction
Currently open trials in the same condition.
- NCT07272395 — Right Ventricular Function Changes After CIED Implantation: The RIGHT-CIED Study · recruiting
- NCT06053580 — Repurposing Valsartan May Protect Against Pulmonary Hypertension · Phase 2 · recruiting
- NCT06424028 — Acute Right Ventricular Infarction Registry · recruiting
- NCT05809310 — Effects Branch PA Stenting d-TGA, ToF and TA · NA · recruiting
- NCT05804240 — TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR · recruiting
Other Montreal Heart Institute trials
Trials by the same sponsor.
- NCT07524335 — Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial · Phase 3 · not yet recruiting
- NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
- NCT07391358 — DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid · NA · not yet recruiting
- NCT05450328 — Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation · Phase 2 · not yet recruiting
- NCT07144722 — Prehabilitation Program for Patients Awaiting Elective Heart Surgery at Increased Risk of Postoperative Complications: F · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04782154 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Montreal Heart Institute
- Last refreshed: 2 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04782154.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing